Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
US Army
Chubb
Cantor Fitzgerald
McKinsey
Farmers Insurance
Federal Trade Commission
Daiichi Sankyo

Generated: April 19, 2018

DrugPatentWatch Database Preview

TORNALATE Drug Profile

« Back to Dashboard

When do Tornalate patents expire, and when can generic versions of Tornalate launch?

Tornalate is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.
Summary for TORNALATE
Drug patent expirations by year for TORNALATE
Synonyms for TORNALATE
(tert-Butyl)(beta-hydroxy-3,4-bis(p-toluoyloxy)phenethyl)ammonium methanesulphonate
(tert-butyl)[beta-hydroxy-3,4-bis(p-toluoyloxy)phenethyl]ammonium methanesulphonate
[4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate; methanesulfonic acid
[4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate; methanesulfonic acid
30392-40-6 (Parent)
30392-41-7
32274-EP2281815A1
32274-EP2301933A1
32274-EP2305640A2
32274-EP2311827A1
4-(2-(t-Butylamino)-1-hydroxyethyl)-o-phenylene di-p-toluate mesilate
4-(2-(tert-Butylamino)-1-hydroxyethyl)-o-phenylene di-p-toluate methanesulfonate (salt)
5-[2-(TERT-BUTYLAMINO)-1-HYDROXYETHYL]-2-(4-METHYLBENZOYLOXY)PHENYL 4-METHYLBENZOATE; METHANESULFONIC ACID
AC1L1THU
ACM30392417
AKOS027378327
alpha((tert-Butylamino)methyl)-3,4-dihydroxybenzyl alcohol 3,4-di-p-toluate methanesulfonate (salt)
AN-5576
Asmalene
Benzoic acid, 4-methyl-, 4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,2-phenylene ester methanesulfonate (salt)
Bitolterol mesilat
Bitolterol mesilate
Bitolterol mesilate (JAN)
BITOLTEROL MESYLATE
Bitolterol mesylate (USAN)
Bitolterol mesylate [USAN]
Bitolterol methanesulfonate
C28H31NO5.CH4O3S
CHEBI:3134
CHEMBL1200405
D00684
Effectin
EINECS 250-177-5
LS-154253
OR076475
OR255480
p-Toluic acid, 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene ester, methanesulfonate(salt)
Produrol
S-1540
SCHEMBL4371
Tornalate (TN)
WIN 32784
WIN-32784

US Patents and Regulatory Information for TORNALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TORNALATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
US Department of Justice
McKinsey
Cipla
Argus Health
Boehringer Ingelheim
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.